Tilray Brands (TLRY) Retained Earnings (2017 - 2026)
Tilray Brands' (TLRY) quarterly Retained Earnings came in at -$5.0 billion in Q2 2026, down 2.5% YoY from -$5.1 billion in Q2 2025, and down 1.01% on a QoQ basis from -$4.9 billion in Q1 2026.
Tilray Brands (TLRY) Retained Earnings (2017 - 2026) Analysis & Trends
Tilray Brands (TLRY) has 10 years of Retained Earnings data on file, last reported at -$5.0 billion in Q2 2026.
- Quarterly Retained Earnings fell 2.5% year-over-year to -$5.0 billion in Q2 2026, while the trailing twelve-month figure through May 2026 was -$5.0 billion (down 2.5% YoY) and the FY2026 annual result came in at -$5.0 billion, down 2.5% from the prior year.
- Retained Earnings eased to -$5.0 billion in Q2 2026, from -$4.9 billion in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of -$484.7 million in Q1 2022 to a low of -$5.0 billion in Q2 2026.
- A 5-year average of -$2.9 billion and a median of -$2.6 billion in 2024 frame the typical range for Retained Earnings.
- Annual changes were most pronounced in 2022 — Retained Earnings sank 11624.71% — and 2026, when it fell 2.5%.
- Tracing TLRY's Retained Earnings over 5 years: stood at -$1.1 billion in 2022, then tumbled by 129.34% to -$2.5 billion in 2023, then retreated by 9.82% to -$2.8 billion in 2024, then sank by 75.67% to -$4.9 billion in 2025, then declined by 1.56% to -$5.0 billion in 2026.
- The last three Retained Earnings figures came in at -$5.0 billion (Q2 2026), -$4.9 billion (Q1 2026), and -$4.9 billion (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | 37.15 Bn |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn | 28.26 Bn |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn | 14.65 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 4.18 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 9.16 Bn |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | 18.56 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 724.00 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 8.88 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | 3.75 Bn |
| 10 | Tilray Brands | 513.87 Mn | 279.24 Mn | 90.52 Mn | -4.97 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | -4.97 Bn |
| Feb 28, 2026 | -4.92 Bn |
| Nov 30, 2025 | -4.89 Bn |
| Aug 31, 2025 | -4.85 Bn |
| May 31, 2025 | -4.85 Bn |
| Nov 30, 2024 | -2.78 Bn |
| Aug 31, 2024 | -2.70 Bn |
| May 31, 2024 | -2.66 Bn |
| Feb 29, 2024 | -2.63 Bn |
| Nov 30, 2023 | -2.54 Bn |
| Aug 31, 2023 | -2.49 Bn |
| May 31, 2023 | -2.42 Bn |
| Feb 28, 2023 | -2.28 Bn |
| Nov 30, 2022 | -1.11 Bn |
| Aug 31, 2022 | -1.04 Bn |
| May 31, 2022 | -962.85 Mn |
| Feb 28, 2022 | -484.71 Mn |
| Nov 30, 2021 | 9.60 Mn |
| Aug 31, 2021 | 51.25 Mn |
| May 31, 2021 | -486.05 Mn |